HGF and melanoma: These siESRP1-transfected melanoma cells also demonstrated lower migratory potential under hepatocyte growth factor (HGF) treatment (HGF, a factor released during inflammation or tissue disruption, should increase the migration of CD44v6-positive melanoma cells).